About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.

ImmunoPrecise Antibodies Ltd., an AI-powered antibody company, has partnered with RIBOPRO, a technology provider specializing ...

This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten rich off the coronavirus pandemic.